WALVAX BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.33 CNY | +3.54% |
|
+2.43% | -39.05% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Quotes 5-day view
End-of-day quote Shenzhen S.E.| 2024-04-22 | 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|---|
| Last | 14.29 ¥ | 14.25 ¥ | 14.14 ¥ | 13.84 ¥ | 14.33 ¥ |
| Volume | 14 827 800 | 14 354 610 | 13 425 930 | 26 536 100 | 24 848 250 |
| Change | +2.14% | -0.28% | -0.77% | -2.12% | +3.54% |
| Opening | 14.05 | 14.23 | 14.24 | 13.46 | 13.77 |
| High | 14.47 | 14.39 | 14.25 | 14.07 | 14.35 |
| Low | 13.87 | 14.06 | 13.93 | 13.13 | 13.76 |
Performance
| 1 day | +3.54% | ||
| 1 week | +2.43% | ||
| Current month | -6.83% | ||
| 1 month | -10.77% | ||
| 3 months | -22.54% | ||
| 6 months | -34.51% | ||
| Current year | -39.05% | ||
| 1 year | -55.20% | ||
| 3 years | -76.12% | ||
| 5 years | -46.27% | ||
| 10 years | +147.45% |
Volumes
marketsDaily volume
24 848 250
Avg. Volume 20 sessions
17 285 467
Avg. Volume 20 sessions CNY
247 700 742.11
Avg. Volume 20 sessions USD
34 184 931.72
Record volume 1
268 063 200
Record volume 2
239 207 300
Record volume 3
162 313 000
Capital turnover ratio
0.01
Float rotation
0.04
Basic data
Capitalization (CNY)
22 917 096 660
Capitalization (USD)
3 162 765 593
Net sales (CNY)
4 113 772 330
Net sales (USD)
567 737 605
Number of employees
2 388
Sales / Employee (CNY)
1 722 685
Sales / Employee (USD)
237 746
Free-Float
27.42 %
Free-Float capitalization (CNY)
6 346 241 716
Free-Float capitalization (USD)
875 838 473
Average Daily Capital Traded
1.08%
Highs and lows
1 week
13.13
14.47
1 month
13.1316.12
Current year
13.1323.66
1 year
13.1332.23
3 years
13.1396.73
5 years
13.1396.73
10 years
5.0596.73
Indicators
Moving average 5 days
14.17
Moving average 20 days
14.70
Moving average 50 days
16.53
Moving average 100 days
18.93
Price spread / (MMA5)
-1.12%
Price spread / (MMA20)
+2.58%
Price spread / (MMA50)
+15.35%
Price spread / (MMA100)
+32.10%
STIM
RSI 9 days
43.41
RSI 14 days
39.27
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.54% | +2.43% | -39.05% | -55.20% | 3.16B | ||
| -1.85% | +1.41% | -4.66% | -10.60% | 86.13B | ||
| -1.28% | -1.41% | +1.32% | -1.66% | 39.82B | ||
| +3.18% | +7.47% | -19.27% | -27.48% | 30.42B | ||
| +0.65% | +2.76% | +57.86% | +46.08% | 25.23B | ||
| +0.98% | -1.28% | -17.69% | -29.72% | 11.6B | ||
| +1.81% | -13.98% | -43.00% | -35.34% | 11.51B | ||
| +7.67% | +2.31% | -9.14% | -9.50% | 11.95B | ||
| +0.07% | +7.66% | +5.24% | +7.25% | 8.71B | ||
| +1.56% | +17.92% | -8.42% | +2.49% | 8.12B | ||
| +1.57% | +1.23% | +2.29% | +20.02% | 7.72B | ||
| 0.00% | +3.15% | +76.35% | +283.44% | 6.69B | ||
| -0.96% | +2.57% | -10.12% | +16.72% | 6.59B | ||
| -0.80% | -0.49% | -7.72% | +6.85% | 6.49B | ||
| +4.03% | +4.90% | -16.71% | -41.12% | 6.01B | ||
| +3.71% | +0.48% | -45.74% | -6.93% | 5.41B | ||
| Average | +1.49% | +2.06% | -4.91% | +10.33% | ||
| Weighted average by Cap. | +0.35% | +1.48% | -1.33% | +1.13% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -39.05% | ||
| 2023 | -41.50% | ||
| 2022 | -28.49% | ||
| 2021 | +45.75% | ||
| 2020 | +18.87% | ||
| 2019 | +69.84% | ||
| 2018 | +4.66% | ||
| 2017 | +67.43% | ||
| 2016 | -17.30% | ||
| 2015 | +95.89% | ||
| 2014 | +34.60% | ||
| 2013 | +4.39% | ||
| 2012 | -1.73% | ||
| 2011 | -48.64% | ||
| 2010 | -2.31% |
- Stock Market
- Equities
- 300142 Stock
- Quotes Walvax Biotechnology Co., Ltd.
